Avantor, Inc.
AVTRAvantor, Inc. (AVTR) is a global supplier of advanced materials, products, and services to the life sciences, healthcare, and advanced technology industries. The company provides a wide range of specialized consumables, equipment, and custom solutions used in laboratory research, development, and manufacturing processes. Avantor's offerings support scientific innovation and commercialization across various sectors, including pharmaceuticals, biotechnology, and industrial applications.
Company News
The Iran-Israel conflict and potential Strait of Hormuz disruption are creating supply chain pressures on medical supplies through petrochemical derivatives. Key inputs like naphtha and methanol used in pharmaceutical packaging and drug synthesis are experiencing price increases. While hospitals haven't yet felt the impact, analysts expect cost p...
Multiple China-focused stocks and emerging market ETFs have fallen into deeply oversold territory with exceptionally low RSI readings, potentially setting up for sharp rebounds if risk sentiment improves. The oversold list is dominated by Chinese internet and tech names alongside broader Asian and emerging market exposures, though investors are c...
Despite Avantor's stock declining 46% over the past year, Chicago-based Kinney Asset Management increased its position to 1.85 million shares worth $23.03 million, making it the fund's largest holding. The move signals confidence in the company's turnaround potential, as management authorizes a $500 million share repurchase program while the comp...
Avantor, Inc. faces a class action lawsuit alleging that company executives failed to disclose weakening competitive positioning and increased competitive intensity affecting its Laboratory Solutions business. The company cut guidance multiple times in 2025 after reporting weak organic sales growth. Stock prices fell significantly following each ...
Levi & Korsinsky, LLP has filed class action securities lawsuits against Avantor, Inc. (AVTR), Coupang, Inc. (CPNG), and DeFi Technologies (DEFT) alleging securities fraud. Avantor investors claim the company made false statements about its competitive positioning and concealed negative effects from increased competition during March 5, 2024 to O...
